8:15–10:15 A.M.

CORRELATIONBETWEEN LYNCH SYNDROMEAND COLON CANCER

8:15–8:30 A.M.

Case Study Presentation

 

Marc Williams, Director, Intermountain Healthcare Clinical Genetics Institute, LDS Hospital

8:30–9:00 A.M.

Lynch Syndrome Panelists

 

Mark Boguski, Associate Professor, Center for Biomedical Informatics, Harvard Medical School

Roy Gandolfi, Associate Medical Director, SelectHealth

Don Lyman, Chief, Chronic Disease and Injury Control Division, California Department of Public Health

Dennis Salisbury, Family Practice Physician, Rocky Mountain Clinic, Butte, MT

Andrew Spiegel, CEO, Colon Cancer Alliance

9:00–9:45 A.M.

Panel discussion

9:45–10:15 A.M.

Roundtable discussion

10:15–10:30 A.M.

BREAK

10:30–12:30 P.M.

PHARMACOGENOMIC TESTING FOR WARFARIN DOSING

10:30–10:45 A.M.

Case Study Presentation

 

David Veenstra, Associate Professor, Pharmaceutical Outcomes Research and Policy Program and Institute for Public Health Genetics, University of Washington

10:45–11:15 A.M.

Warfarin Panelists

 

Anna Garrett, Manager, Outpatient Clinical Pharmacy Programs, Mission Hospital, Asheville, NC



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement